Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Prostate cancer].

Katsuyuki Karasawa1

  • 1Dept. of Radiology, Tokyo Metropolitan Komagome Hospital.

Gan to Kagaku Ryoho. Cancer & Chemotherapy
|April 3, 2003
PubMed
Summary

This study reviews prostate cancer (PC) treatments, including surgery, radiotherapy, and hormone therapy. It highlights the need for long-term data on treatment effectiveness and toxicity to guide patient choices.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multi-Institutional Phase II Study on the Efficacy and Safety of Dynamic Tumor-Tracking, Moderately Hypofractionated Intensity-Modulated Radiotherapy in Patients With Locally Advanced Pancreatic Cancer.

Cancer medicine·2025
Same author

Prospective external validation of radiomics-based predictive model of distant metastasis after dynamic tumor tracking stereotactic body radiation therapy in patients with non-small-cell lung cancer: A multi-institutional analysis.

Journal of applied clinical medical physics·2024
Same author

Phase I/II study of stereotactic body radiotherapy boost in patients with cervical cancer ineligible for intracavitary brachytherapy.

Japanese journal of radiology·2024
Same author

Population-based asymmetric margins for moving targets in real-time tumor tracking.

Medical physics·2023
Same author

Dynamic tumor-tracking stereotactic body radiotherapy with real-time monitoring of liver tumors using a gimbal-mounted linac: A multi-institutional phase II study.

Clinical and translational radiation oncology·2023
Same author

A multicenter, randomized, placebo-controlled phase IIb trial of an autologous formalin-fixed tumor vaccine for newly diagnosed glioblastomas.

Journal of neurosurgery·2023

Area of Science:

  • Oncology
  • Radiation Oncology
  • Urology

Context:

  • Prostate cancer (PC) management involves surgery and radiotherapy, with ongoing debate on their comparative effectiveness.
  • Previous randomized controlled trials (RCTs) have yielded inconclusive results regarding the equivalence of surgery and radiotherapy for PC control.
  • Patient counseling requires comprehensive information on both treatment efficacy and toxicity profiles.

Purpose:

  • To evaluate the role of dose escalation studies in improving PC biochemical control rates.
  • To emphasize the necessity of RCTs for determining optimal radiation doses across different PC risk groups.
  • To underscore the importance of long-term follow-up for assessing biochemical control and normal tissue toxicity.

Summary:

  • Hormone manipulation is a standard treatment for high-risk PC, often used adjunctively with radiotherapy to improve outcomes.
  • Combined modality treatments, including neoadjuvant/adjuvant hormone therapy with radiotherapy, have shown enhanced biochemical control and survival in some RCTs.
  • Brachytherapy presents a promising approach for dose concentration, with its future potential as a standard treatment dependent on operator skill and further validation.

Impact:

  • Improved understanding of treatment toxicity and efficacy is crucial for informed patient decision-making in prostate cancer care.
  • Advancements in radiotherapy techniques and combined-modality treatments are enhancing the therapeutic ratio for prostate cancer.
  • Further research is needed to optimize hormone therapy timing and duration, and radiotherapy dosage for personalized PC treatment.

Related Experiment Videos